Stay updated with breaking news from Diffusing Alpha Emitters Radiation Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO 2024 Congress in Glasgow -
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -
JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April –– 89% CR, two-year lo...